vs
Side-by-side financial comparison of CIMPRESS plc (CMPR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.4× CIMPRESS plc). CIMPRESS plc runs the higher net margin — 4.7% vs 4.4%, a 0.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 11.0%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $139.5M).
Cimpress plc is an American Irish-domiciled multinational technology company that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods. Those products are sold to small businesses, graphic designers and consumers through a number of customer-facing brands that Cimpress operates.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CMPR vs ONC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $49.3M | $66.5M |
| Gross Margin | 46.8% | 90.5% |
| Operating Margin | 8.5% | 12.4% |
| Net Margin | 4.7% | 4.4% |
| Revenue YoY | 11.0% | 32.8% |
| Net Profit YoY | -19.2% | 143.8% |
| EPS (diluted) | $1.95 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $863.3M | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $929.2M | ||
| Q1 24 | — | $751.7M |
| Q4 25 | $49.3M | $66.5M | ||
| Q3 25 | $7.6M | $124.8M | ||
| Q2 25 | — | $94.3M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-151.9M | ||
| Q3 24 | — | $-121.3M | ||
| Q2 24 | — | $-120.4M | ||
| Q1 24 | — | $-251.2M |
| Q4 25 | 46.8% | 90.5% | ||
| Q3 25 | 46.7% | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 8.5% | 12.4% | ||
| Q3 25 | 5.7% | 11.5% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | — | -12.0% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -34.8% |
| Q4 25 | 4.7% | 4.4% | ||
| Q3 25 | 0.9% | 8.8% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | — | -12.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | — | -33.4% |
| Q4 25 | $1.95 | $0.05 | ||
| Q3 25 | $0.30 | $0.08 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | — | $-0.09 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $258.0M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $-530.7M | $4.4B |
| Total Assets | $2.1B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $258.0M | $4.5B | ||
| Q3 25 | $200.5M | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-530.7M | $4.4B | ||
| Q3 25 | $-571.3M | $4.1B | ||
| Q2 25 | — | $3.8B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | — | $3.4B |
| Q4 25 | $2.1B | $8.2B | ||
| Q3 25 | $2.0B | $7.6B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | — | $5.9B | ||
| Q3 24 | — | $5.8B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $164.7M | $417.3M |
| Free Cash FlowOCF − Capex | $139.5M | $379.8M |
| FCF MarginFCF / Revenue | 13.4% | 25.4% |
| Capex IntensityCapex / Revenue | 2.4% | 2.5% |
| Cash ConversionOCF / Net Profit | 3.34× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.7M | $417.3M | ||
| Q3 25 | $25.1M | $402.6M | ||
| Q2 25 | — | $263.6M | ||
| Q1 25 | — | $44.1M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | — | $188.4M | ||
| Q2 24 | — | $-95.6M | ||
| Q1 24 | — | $-308.6M |
| Q4 25 | $139.5M | $379.8M | ||
| Q3 25 | $-1.3M | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | — | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M | ||
| Q1 24 | — | $-465.1M |
| Q4 25 | 13.4% | 25.4% | ||
| Q3 25 | -0.1% | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | — | -61.9% |
| Q4 25 | 2.4% | 2.5% | ||
| Q3 25 | 3.1% | 3.4% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | 3.34× | 6.28× | ||
| Q3 25 | 3.28× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMPR
| Vista | $532.8M | 51% |
| Print Brothers | $219.9M | 21% |
| National Pen | $150.9M | 14% |
| The Print Group | $115.2M | 11% |
| All Other Businesses | $67.2M | 6% |
ONC
Segment breakdown not available.
